This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Tyrosine kinase inhibitors, nilotinib and radotinib, suppress both catalytic function and mRNA expression of human cytochrome P450 2J2 and 2C8, Drug Metabolism and Pharmacokinetics, August 2025, Elsevier,
DOI: 10.1016/j.dmpk.2025.101501.
You can read the full text:
The following have contributed to this page
